Hydroxy tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of RHS moiety (Part-3)
作者:Sheo B. Singh、David E. Kaelin、Jin Wu、Lynn Miesel、Christopher M. Tan、Charles Gill、Todd Black、Ravi Nargund、Peter T. Meinke、David B. Olsen、Armando Lagrutta、Changqing Wei、Xuanjia Peng、Xiu Wang、Hideyuki Fukuda、Ryuta Kishii、Masaya Takei、Tomoko Takeuchi、Taku Shibue、Kohei Ohata、Hisashi Takano、Shizuka Ban、Akinori Nishimura、Yasumichi Fukuda
DOI:10.1016/j.bmcl.2015.04.063
日期:2015.6
Novel bacterial topoisomerase inhibitors (NBTIs) are a new class of broad-spectrum antibacterial agents targeting bacterial Gyrase A and ParC and have potential utility in combating antibiotic resistance. (R)-Hydroxy-1,5-naphthyridinone left-hand side (LHS) oxabicyclooctane linked pyridoxazinone right-hand side (RHS) containing NBTIs showed a potent Gram-positive antibacterial profile. SAR around the RHS moiety, including substitutions around pyridooxazinone, pyridodioxane, and phenyl propenoids has been described. A fluoro substituted pyridoxazinone showed an MIC against Staphylococcus aureus of 0.5 mu g/mL with reduced functional hERG activity (IC50 333 mu M) and good in vivo efficacy [ED90 12 mg/kg, intravenous (iv) and 15 mg/kg, oral (p.o.)]. A pyridodioxane-containing NBTI showed a S. aureus MIC of 0.5 mu g/mL, significantly improved hERG IC50 764 mu M and strong efficacy of 11 mg/kg (iv) and 5 mg/kg (p.o.). A phenyl propenoid series of compounds showed potent antibacterial activity, but also showed potent hERG binding activity. Many of the compounds in the hydroxy-tricyclic series showed strong activity against Acinetobacter baumannii, but reduced activity against Escherichia coli and Pseudomonas aeruginosa. Bicyclic heterocycles appeared to be the best RHS moiety for the hydroxy-tricyclic oxabicyclooctane linked NBTIs. (C) 2015 Elsevier Ltd. All rights reserved.